Get in Touch

Edit Template

CLINICAL TRIAL MANAGEMENT​

Early Phase Clinical Trial Services

Phase I & II Clinical Trials: Precision Dose Escalation, Safety, and Efficacy Evaluation. Our CRO delivers expert support for Phase I and II studies, focusing on strategic dose escalation, rigorous safety assessments, and insightful efficacy evaluations. Elevate your research with our specialized capabilities, guiding you through critical early-stage trials with precision and expertise. Partner with us to navigate the complexities of initial clinical testing, ensuring comprehensive data collection and regulatory compliance. Maximize the impact of your research with our tailored solutions and dedicated team. Explore our Phase I & II services to accelerate your path to successful drug development

Early Phase Clinical Trial Services

Embarking on early phase clinical trials, particularly Phase I and II studies, is a critical juncture in drug development where precision and expertise are paramount. At our organization, we offer a comprehensive suite of services tailored specifically for Phase I and II clinical trials, designed to navigate the intricate landscape of early-stage drug development with finesse and efficacy.

One of the foundational pillars of our service is precision dose escalation. We understand the delicate balance required to determine optimal dosage levels while ensuring the safety and well-being of trial participants. Our team of experts employs sophisticated methodologies and state-of-the-art technologies to guide strategic dose escalation, maximizing the efficiency of your trial while mitigating risks.

Safety assessment is another cornerstone of our Phase I and II clinical trial services. We prioritize rigorous safety monitoring throughout every stage of the trial, employing robust protocols and advanced monitoring techniques to identify and mitigate any potential adverse effects promptly. By maintaining a steadfast focus on safety, we provide trial sponsors with the confidence and assurance necessary to progress through the development pipeline.

Moreover, our commitment to efficacy evaluation is unwavering. We employ innovative approaches and cutting-edge methodologies to assess the therapeutic efficacy of investigational treatments accurately. Our comprehensive efficacy evaluations yield invaluable insights into the potential clinical benefits of your drug candidates, empowering informed decision-making and accelerating the development process.

Partnering with us means gaining access to a dedicated team of experts who are deeply invested in the success of your research endeavors. Our tailored solutions are designed to address the unique challenges and requirements of early phase clinical trials, ensuring seamless execution and optimal outcomes. From protocol development to regulatory compliance, we provide comprehensive support every step of the way, allowing you to focus on advancing your drug candidates with confidence.

Explore our Phase I & II services today and discover how we can accelerate your path to successful drug development. With our expertise and specialized capabilities, you can navigate the complexities of early-stage trials with precision and confidence, ultimately bringing transformative therapies to market for the benefit of patients worldwide."​

Late Phase Clinical
Trial Services

In late phase clinical trials (Phase III and IV), real-world evidence generation, post-marketing surveillance, and comparative effectiveness research.

In late-phase Clinical Trials (Phase III and IV)

The focus shifts towards real-world evidence generation, post-marketing surveillance, and comparative effectiveness research, marking a crucial stage in the drug development continuum. At our organization, we offer specialized services tailored specifically for Phase III and IV clinical trials, designed to harness the power of real-world data and drive evidence-based decision-making with precision and efficacy.

Real-world Evidence Generation

Lies at the heart of our late-phase clinical trial services. We recognize the importance of supplementing traditional clinical trial data with real-world data to provide a comprehensive understanding of a drug's safety, effectiveness, and value in real-world settings. Our team employs innovative methodologies and advanced analytics to capture and analyze real-world data, generating robust evidence that informs clinical practice and regulatory decision-making.

Post-marketing Surveillance

This is another critical component of our late-phase clinical trial services. We prioritize proactive monitoring of drug safety and efficacy following regulatory approval, ensuring early detection and mitigation of any potential safety concerns. Our comprehensive surveillance programs provide stakeholders with timely and actionable insights, facilitating the continuous improvement of patient outcomes and the optimization of healthcare delivery.

Comparative Effectiveness Research

Furthermore, we specialize in comparative effectiveness research, leveraging real-world data to evaluate the relative effectiveness of different treatment options in routine clinical practice. By conducting comparative effectiveness studies, we empower healthcare providers, payers, and policymakers to make informed decisions about treatment selection and resource allocation, ultimately improving patient care and healthcare outcomes.

Partnering with Us

Means gaining access to a dedicated team of experts who are committed to advancing the science of late-phase clinical research. Our tailored solutions are designed to address the unique challenges and complexities of Phase III and IV trials, ensuring rigorous study design, meticulous execution, and comprehensive data analysis.

Explore our Late-phase Clinical Trial Services

Explore our late-phase clinical trial services today and discover how we can help you generate compelling real-world evidence, optimize post-marketing surveillance, and conduct impactful comparative effectiveness research. With our expertise and specialized capabilities, you can navigate the complexities of late-phase trials with confidence, ultimately driving meaningful improvements in patient care and healthcare delivery.

Estimating the appropriate sample size is crucial for ensuring the trial has sufficient statistical power to detect meaningful differences between treatment groups.
  • We offer expert sample size estimation services tailored to your clinical trial needs. Our approach involves a thorough analysis of study objectives, endpoints, and desired statistical power to ensure your trial is adequately powered to detect meaningful differences between treatment groups.
  • Leveraging advanced statistical methods and extensive experience, we provide accurate sample size calculations across diverse therapeutic areas and study designs. Our team collaborates closely with sponsors to understand specific research questions and desired outcomes, ensuring that sample size estimates address these objectives effectively.
  • Additionally, we offer strategic guidance on study design considerations and endpoint selection to optimize trial efficiency and success. By combining our statistical expertise with clinical insights, we ensure that your protocol is meticulously designed to meet regulatory requirements and achieve your research goals.
  • With our precise approach to sample size estimation in Latin America, you can trust that your clinical trial will be powered to yield reliable and clinically meaningful results, setting the stage for successful drug development and regulatory approval.

 

Clinical trials must adhere to regulatory requirements set forth by governing bodies such as Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) in Mexico or the Food and Drug Administration (FDA) in the United States.
  • As part of the regulatory compliance assistance service provided by Althian, it is imperative to ensure that clinical trials adhere meticulously to the regulatory requirements established by governing bodies such as the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) in Mexico or the Food and Drug Administration (FDA) in the United States. These regulatory bodies play a pivotal role in safeguarding public health by setting and enforcing stringent standards for the conduct of clinical research.
  • In this context, Althian’s role is multifaceted, encompassing the comprehensive management and oversight of clinical trials to ensure compliance with all applicable regulations and guidelines in Latin America. This includes facilitating the preparation and submission of regulatory documents, such as investigational new drug applications (INDs) or clinical trial authorization (CTA) submissions, to obtain regulatory approval for the initiation of clinical trials.
  • Furthermore, Althian works closely with sponsors, investigators, and regulatory authorities to address any regulatory issues or concerns that may arise during the course of the trial. This proactive approach not only helps to streamline the regulatory approval process but also ensures that the trial is conducted in accordance with the highest ethical and scientific standards.
  • By providing expert guidance and support in navigating the complex regulatory landscape, Althian plays a vital role in facilitating the successful execution of clinical trials while ensuring compliance with regulatory requirements. This ultimately contributes to the advancement of medical science and the development of innovative therapies for the benefit of patients worldwide.
This involves ensuring that the trial respects the rights, safety, and well-being of participants, and that it is conducted in accordance with ethical principles outlined in documents such as the Declaration of Helsinki and Good Clinical Practice (GCP) guidelines.
  • Protocol development and study design are fundamental pillars of clinical research, encompassing a multifaceted process that requires careful consideration of ethical principles and regulatory requirements. At our organization, we prioritize ethical considerations throughout every stage of protocol development and study design, recognizing the critical importance of safeguarding the rights, safety, and well-being of trial participants.
  • The process of protocol development begins with a meticulous examination of the research question or hypothesis, laying the foundation for the study objectives, endpoints, and methodology. Our team of experts collaborates closely with sponsors, investigators, and regulatory authorities to ensure that the protocol is scientifically rigorous, methodologically sound, and ethically robust.
  • Ethical considerations permeate every aspect of protocol development, guiding decisions related to participant selection, informed consent procedures, risk assessment, and data collection methods. We adhere strictly to ethical principles outlined in international guidelines, such as the Declaration of Helsinki and the Belmont Report. We also ensure compliance with relevant regulatory requirements specific to Latin America, ensuring that the rights and welfare of trial participants are protected at all times.
  • In addition to ethical considerations inherent in protocol development and study design, we place a strong emphasis on transparency and accountability throughout the research process. We believe in fostering open communication and collaboration among all stakeholders, including sponsors, investigators, regulatory authorities, and trial participants, to ensure that ethical standards are upheld and research integrity is maintained.
  • By prioritizing ethical considerations in protocol development and study design, we demonstrate our commitment to upholding the highest standards of research ethics and integrity. Our goal is to conduct clinical trials that not only generate valuable scientific knowledge but also uphold the principles of respect for persons, beneficence, and justice, thereby contributing to the advancement of medical science and the improvement of patient care.
Post-2

Site Training

We offer comprehensive training programs for clinical trial sites to ensure that all personnel involved in the study are fully informed and equipped to conduct the trial according to protocol and regulatory requirements. Our training covers various aspects, including study procedures, regulatory compliance, patient safety, and data collection.

Patient safety is a top priority in clinical research​

Our training programs place a strong emphasis on ensuring the well-being of trial participants. We provide site personnel with the knowledge and tools to recognize and respond to adverse events, protocol deviations, and other safety concerns promptly and effectively.

We Offer Guidance on Data Collection Procedures​

Including electronic data capture systems, case report form completion, and data entry protocols. Our goal is to equip site personnel with the skills and resources necessary to collect high-quality data that meets regulatory standards and contributes to the success of the study.

Investing in Comprehensive Site Training Programs

We demonstrate our commitment to supporting clinical trial sites and ensuring the successful conduct of research. Our goal is to empower site personnel with the knowledge, skills, and confidence to execute their roles effectively, ultimately advancing medical science and improving patient care.

Site Monitoring and Auditing

Our experienced monitors conduct regular visits to clinical trial sites to oversee study conduct, verify data accuracy, and ensure compliance with protocol and regulatory requirements. We also provide auditing services to assess site performance, identify areas for improvement, and ensure data integrity throughout the trial.

Site Feasibility

We assess the feasibility of potential clinical trial sites by evaluating factors such as patient population, site capabilities, regulatory environment, and logistical considerations. This helps sponsors identify suitable sites for their studies and optimize site selection to meet study objectives efficiently.

Beginning with a focus on efficiency and effectiveness, our approach to clinical trial planning centers on thorough site feasibility assessments. We evaluate potential trial sites by examining key factors such as patient population, site capabilities, regulatory landscape, and logistical considerations.
0
These comprehensive assessments serve to guide sponsors in identifying optimal sites for their studies across Mexico and other Latin American nations. By delving into demographics, medical infrastructure, and resource availability, we empower sponsors to make informed decisions regarding site selection.
0
Furthermore, our assessment of regulatory environments ensures that chosen sites adhere to applicable regulations, expediting study initiation and regulatory approval processes. Additionally, we consider logistical aspects like accessibility, transportation, and infrastructure to optimize site selection and streamline study operations.
0
Through our expertise in site feasibility assessments, sponsors can strategically select sites that align with study objectives and maximize efficiency. This commitment to thorough assessment ensures that clinical trials are conducted at sites best suited to drive successful research outcomes.
0
Contact us today to leverage our expertise and ensure your clinical trials are conducted with precision and success. Let Althian be your trusted partner in achieving your research goals.
0

Patient Recruitment and Retention Strategies

Our patient recruitment and retention strategies are designed to attract and retain study participants, ensuring timely enrollment and retention throughout the trial. We employ targeted outreach, innovative marketing techniques, and patient engagement strategies to maximize recruitment and minimize dropout rates.

At Althian, we understand the fundamental role of patient recruitment and retention in the success of clinical trials. Our strategies are crafted to ensure timely enrollment and sustained engagement throughout the trial duration.

 

We employ a multifaceted approach that includes targeted outreach, innovative marketing techniques, and patient engagement strategies tailored to Latin American countries. Through targeted outreach efforts, we reach potential participants who meet the study’s eligibility criteria, utilizing channels like social media, online advertising, and community events to raise awareness and encourage participation.

In addition to targeted outreach, we leverage innovative marketing techniques to effectively communicate the benefits of participation and address any concerns. Engaging multimedia content, informative materials, and interactive platforms are utilized to capture the interest of prospective participants and motivate them to enroll.

Once enrolled, our focus shifts to patient retention. Regular communication, incentives, and participant support are provided to maintain engagement and minimize dropout rates. Participants are empowered through education about their role in the study, the importance of their contribution, and any potential risks or benefits involved.

Althian’s patient recruitment and retention strategies are tailored to each study’s unique needs, ensuring maximum participation and contributing to successful trial completion. With our comprehensive approach, we aim to maximize recruitment and retention rates, ultimately driving the success of clinical trials.

Expertise and commitment to excellence

Look no further than Althian, a leading company specializing in a wide range of clinical research services.

Clinical research solutions

Company

Clinical Trial Services

Regulatory Affairs

Data Management and Analysis

Pharmacovigilance and Drug Safety

Other Services

Features

Contact Us

Engagement

Builder

Help

Privacy Policy

Terms

Conditions

Services

Reliable and experienced partner in clinical research

You have been successfully Subscribed! Ops! Something went wrong, please try again.
© 2023 Created with Royal Elementor Addons